BRIEF published on 11/04/2026 at 10:50, 2 days ago BRAIN Biotech et Syngenta collaborent sur des innovations en matière d'agriculture durable Biotechnologie Agriculture Durable Innovation Agricole Biologie Synthétique Souche Microbienne
BRIEF published on 11/04/2026 at 10:50, 2 days ago BRAIN Biotech and Syngenta Collaborate on Sustainable Farming Innovations Biotechnology Sustainable Farming Agricultural Innovation Synthetic Biology Microbial Strain
PRESS RELEASE published on 11/04/2026 at 10:45, 2 days ago BRAIN Biotech and Syngenta form strategic cooperation applying synthetic biology to drive innovations in sustainable farming solutions
BRIEF published on 09/09/2026 at 13:25, 1 month 26 days ago BRAIN Biotech AG obtient un paiement d'étape de 11,51 millions d'euros BRAIN Biotech AG Situation Financière Paiement D'étape Deucrictibant Royal Pharma
BRIEF published on 09/09/2026 at 13:25, 1 month 26 days ago BRAIN Biotech AG Secures EUR 11.51 Million Milestone Payment Financial Position BRAIN Biotech AG Milestone Payment Deucrictibant Royalty Pharma
PRESS RELEASE published on 09/09/2026 at 13:20, 1 month 26 days ago BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma BRAIN Biotech AG receives EUR 11.51 million milestone payment from Royalty Pharma, enhancing financial position. Expecting additional future milestone payments. CFO sees positive developments Financial Position BRAIN Biotech AG Milestone Payment Royalty Pharma Future Milestones
BRIEF published on 09/09/2026 at 13:17, 1 month 26 days ago BRAIN Biotech AG obtient 11,51 millions d'euros de Royalty Pharma BRAIN Biotech Impact Financier Paiement D'étape Deucrictibant Royal Pharma
BRIEF published on 09/09/2026 at 13:17, 1 month 26 days ago BRAIN Biotech AG Secures EUR 11.51 Million from Royalty Pharma Financial Impact BRAIN Biotech Milestone Payment Deucrictibant Royalty Pharma
PRESS RELEASE published on 09/09/2026 at 13:12, 1 month 26 days ago EQS-Adhoc: BRAIN Biotech AG Receives EUR 11.51 Million Major Milestone Payment from Royalty Pharma BRAIN Biotech AG receives EUR 11.51 million milestone payment from Royalty Pharma for pharma compound development Development BRAIN Biotech AG Milestone Payment Royalty Pharma Pharma Compound
BRIEF published on 08/27/2026 at 07:35, 2 months 10 days ago BRAIN Biotech Reports 9M Results, Targets Break-even EBITDA Financial Results Revenue Forecast Revenue Decline EBITDA Target CEO Commentary
Published on 11/06/2026 at 05:15, 6 hours 16 minutes ago Valeo and QNX Unveil A New Smart Camera Platform at CIIE, Secures Multiple Design Wins
Published on 11/06/2026 at 00:53, 10 hours 38 minutes ago Sekur Private Data Engages Darkstar Capital for Investor Awareness and Sekur Product Distribution
Published on 11/06/2026 at 00:45, 10 hours 46 minutes ago Gabriel Announces Closure of ICSID Annulment Proceedings
Published on 11/06/2026 at 10:28, 1 hour 3 minutes ago Tradegate BSX continues to expand its reach in the German retail investor market
Published on 11/06/2026 at 10:15, 1 hour 16 minutes ago Marco Fuchs Receives EY Entrepreneur Of The Year 2026 Award
Published on 11/06/2026 at 10:05, 1 hour 26 minutes ago Smart City Expo 2026 closes after showing the real impact of urban solutions
Published on 11/06/2026 at 09:58, 1 hour 33 minutes ago EQS-Adhoc: Uniper SE establishes dividend policy
Published on 11/06/2026 at 09:42, 1 hour 48 minutes ago Silver for the Thorium Pioneer: Emerald Horizon Takes Second Place at “Innovator of the Year” 2026
Published on 11/06/2026 at 09:07, 2 hours 23 minutes ago Mise à disposition de la note d'information de M14 dans le cadre de l'OPR visant les actions BOURRELIER GROUP
Published on 11/06/2026 at 09:04, 2 hours 26 minutes ago Mise à disposition de la note d'information en réponse établie par BOURRELIER GROUP initiée par M14
Published on 11/05/2026 at 18:21, 17 hours 9 minutes ago Capital et droits de vote au 31 octobre 2026
